Recombinant Human DAPK2 Protein，His

DAPK2 (Death-Associated Protein Kinase 2) is a serine/threonine kinase that plays a critical role in various cellular processes, including apoptosis, autophagy, and immune responses. It is a member of the DAPK family, which is known to be involved in tumor suppression and the regulation of cancer cell survival. The study of DAPK2 has gained prominence due to its potential implications in cancer biology, neurodegenerative diseases, and inflammatory disorders. Recent research has highlighted its involvement in different signaling pathways, making it a target of interest for therapeutic interventions. To further understand its biological functions and mechanisms, the production of recombinant DAPK2 protein is crucial. Recombinant protein enables researchers to study its enzymatic activities, structural properties, and interactions with other cellular molecules under controlled laboratory conditions. This facilitates the development of assays to assess its role in disease models and therapeutic applications, paving the way for novel strategies in cancer treatment and other diseases linked to DAPK2 dysregulation. Furthermore, as a biopharmaceutical target, understanding DAPK2's structural and functional characteristics through recombinant studies can aid in the design of small-molecule inhibitors or modulators, potentially leading to new drug development avenues. Consequently, the analysis of recombinant DAPK2 protein not only expands our knowledge of its biological significance but also enhances the potential for translational research aimed at addressing critical health challenges.